Negative influence of undertreatment in elderly patients with breast cancer;Nachteile für ältere Patientinnen mit Mammakarzinom durch Untertherapie

Strahlentherapie und Onkologie

Volumn 188, Issue 6, 2012, Pages 527-528

  Giordano, F A ^a   Wenz, F ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; HUMAN; NOTE;

EID: 84862680476     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-012-0112-5     Document Type: Note

References (10)

1. Ataseven B, Eiermann W, Molls M et al (2010) Strahlentherapie nach brusterhaltender Therapie. Gynäkologe 43:989-995
2. Berry DA, Cronin KA, Plevritis SK et al (2005) Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 353:1784-1792 (Pubitemid 41549890)
3. Diab SG, Elledge RM, Clark GM (2000) Tumor characteristics and clinical outcome of elderly women with breast cancer. J Natl Cancer Inst 92:550-556 (Pubitemid 30212316)
4. Elkin EB, Ishill NM, Snow JG et al (2010) Geographic access and the use of screening mammography. Med Care 48:349-356
5. Fracheboud J, Groenewoud JH, Boer R et al (2006) Seventy-five years is an appropriate upper age limit for population-based mammography screening. Int J Cancer 118:2020-2025
6. Kimmick G (2001) Adjuvant chemotherapy for breast cancer in older women: emerging evidence to aid in decision making. Curr Treat Options Oncol 12:286-301
7. Nagel G, Röhrig B, Hoyer H et al (2002) Bevölkerungsbezogene Studie über die Anwendung adjuvanter Strahlentherapie bei Patientinnen mit Mammakarzinom. Strahlenther Onkol 178:589-596 (Pubitemid 35387833)
8. Peschel RE, Wilson L, Haffty B et al (1993) The effect of advanced age on the efficacy of radiation therapy for early breast cancer, local prostate cancer and grade III-IV gliomas. Int J Radiat Oncol Biol Phys 26:539-544 (Pubitemid 23182350)
9. Statistisches Bundesamt, 12. koordinierte Bevö lkerungsvorausberechnung 2009 (Variante 1-W1), http://www.destatis.de
10. Yothers G, Sargent DJ, Wolmark N et al (2011) Outcomes among black patients with stage II and III colon cancer receiving chemotherapy: an analysis of ACCENT adjuvant trials. J Natl Cancer Inst 103:1498-1506